Foresters Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$15.5M Sell
138,800
-78,558
-36% -$8.75M 0.31% 108
2019
Q2
$24.1M Sell
217,358
-42,792
-16% -$5.04M 0.43% 70
2019
Q1
$33.8M Buy
260,150
+98,050
+60% +$11.9M 0.59% 45
2018
Q4
$18.8M Buy
+162,100
New +$18.1M 0.35% 95
2018
Q1
Sell
-822
Closed -$69K 490
2017
Q4
$69K Buy
822
+85
+12% +$7.23K ﹤0.01% 576
2017
Q3
$63K Hold
737
﹤0.01% 572
2017
Q2
$61K Buy
+737
New +$60.1K ﹤0.01% 572

Other funds holding LLY

Foresters Investment Management's LLY Position: Q3 2019 in Review

Foresters Investment Management reduced its Eli Lilly (LLY) stake by 36% in Q3 2019, selling an estimated $8.75M and leaving 138,800 shares worth $15.5M. The position accounts for 0.31% of the portfolio, ranked #108.

Foresters Investment Management first reported a position in LLY in Q2 2017 and has held it in 7 quarters since. The position peaked at $33.8M in Q1 2019. 1,525 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Foresters Investment Management held 138,800 shares of Eli Lilly worth $15.5M as of Q3 2019.
  • Foresters Investment Management sold 78,558 Eli Lilly shares in Q3 2019, an estimated $8.75M.
  • Eli Lilly made up 0.31% of Foresters Investment Management's portfolio in Q3 2019, its #108 holding.
  • Foresters Investment Management first reported a position in Eli Lilly in Q2 2017 and has held it in 7 quarters since.
  • Foresters Investment Management's Eli Lilly position peaked at $33.8M in Q1 2019.
  • 1,525 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.